首页 | 本学科首页   官方微博 | 高级检索  
     

利妥昔单抗在肾脏病中的应用
引用本文:刘梓,胡志娟. 利妥昔单抗在肾脏病中的应用[J]. 临床肾脏病杂志, 2021, 21(1): 78-82
作者姓名:刘梓  胡志娟
作者单位:华北理工大学研究生学院,唐山063210;河北省人民医院肾内科,石家庄050051;河北省人民医院肾内科,石家庄050051
摘    要:利妥昔单抗是针对B淋巴细胞表面CD20抗原的单克隆抗体.而浆细胞无CD20抗原.利妥昔单抗对于狼疮肾炎、抗中性粒细胞胞质抗体相关性血管炎、难治性微小病变型肾病、局灶性节段性肾小球硬化症、特发性膜性肾病的治疗是有效的而且安全的,但对IgA肾病无效.本文就利妥昔单抗在肾脏病中的应用作一综述.

关 键 词:利妥昔单抗  狼疮肾炎  抗中性粒细胞胞质抗体相关性血管炎  局灶节段性肾小球硬化  膜性肾病

Applications of rituximab in the treatment of renal diseases
Liu Zi,Hu Zhi-juan. Applications of rituximab in the treatment of renal diseases[J]. Journal Of Clinical Nephrology, 2021, 21(1): 78-82
Authors:Liu Zi  Hu Zhi-juan
Affiliation:(Graduate School,North China University of Science&Technology,Tangshan 063210,China;Department of Nephrology,Hebei Provincial People’s Hospital,Shijiazhuang 050051,China)
Abstract:As a monoclonal antibody targeting CD20 on the surface of B lymphocytes,rituximab causes the dissolution of B cells through immune action.Plasma cells lack CD20 antigen.Rituximab is both effective and safe for lupus nephritis,ANCA-associated vasculitis,refractory minimal change nephropathy,focal segmental glomerulosclerosis and membranous nephropathy,but not for IgA nephropathy.This review summarized the applications of rituximab in the treatment of renal diseases.
Keywords:Rituximab  Lupus nephritis  Anti-neutrophil cytoplasmic antibody-associated vasculitis  Focal segmental glomerulosclerosis  Membranous nephropathy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号